120 related articles for article (PubMed ID: 9556597)
1. The alpha-helical domain near the amino terminus is essential for dimerization of vascular endothelial growth factor.
Siemeister G; Marmé D; Martiny-Baron G
J Biol Chem; 1998 May; 273(18):11115-20. PubMed ID: 9556597
[TBL] [Abstract][Full Text] [Related]
2. Disulfide structure of the heparin binding domain in vascular endothelial growth factor: characterization of posttranslational modifications in VEGF.
Keck RG; Berleau L; Harris R; Keyt BA
Arch Biochem Biophys; 1997 Aug; 344(1):103-13. PubMed ID: 9244387
[TBL] [Abstract][Full Text] [Related]
3. A mutant form of vascular endothelial growth factor (VEGF) that lacks VEGF receptor-2 activation retains the ability to induce vascular permeability.
Stacker SA; Vitali A; Caesar C; Domagala T; Groenen LC; Nice E; Achen MG; Wilks AF
J Biol Chem; 1999 Dec; 274(49):34884-92. PubMed ID: 10574962
[TBL] [Abstract][Full Text] [Related]
4. Solution structure of the heparin-binding domain of vascular endothelial growth factor.
Fairbrother WJ; Champe MA; Christinger HW; Keyt BA; Starovasnik MA
Structure; 1998 May; 6(5):637-48. PubMed ID: 9634701
[TBL] [Abstract][Full Text] [Related]
5. Solution structure of a phage-derived peptide antagonist in complex with vascular endothelial growth factor.
Pan B; Li B; Russell SJ; Tom JY; Cochran AG; Fairbrother WJ
J Mol Biol; 2002 Feb; 316(3):769-87. PubMed ID: 11866530
[TBL] [Abstract][Full Text] [Related]
6. A set of loop-1 and -3 structures in the novel vascular endothelial growth factor (VEGF) family member, VEGF-ENZ-7, is essential for the activation of VEGFR-2 signaling.
Kiba A; Yabana N; Shibuya M
J Biol Chem; 2003 Apr; 278(15):13453-61. PubMed ID: 12551914
[TBL] [Abstract][Full Text] [Related]
7. The carboxyl-terminal domain (111-165) of vascular endothelial growth factor is critical for its mitogenic potency.
Keyt BA; Berleau LT; Nguyen HV; Chen H; Heinsohn H; Vandlen R; Ferrara N
J Biol Chem; 1996 Mar; 271(13):7788-95. PubMed ID: 8631822
[TBL] [Abstract][Full Text] [Related]
8. Mapping of the sites for ligand binding and receptor dimerization at the extracellular domain of the vascular endothelial growth factor receptor FLT-1.
Barleon B; Totzke F; Herzog C; Blanke S; Kremmer E; Siemeister G; Marmé D; Martiny-Baron G
J Biol Chem; 1997 Apr; 272(16):10382-8. PubMed ID: 9099677
[TBL] [Abstract][Full Text] [Related]
9. An antagonistic vascular endothelial growth factor (VEGF) variant inhibits VEGF-stimulated receptor autophosphorylation and proliferation of human endothelial cells.
Siemeister G; Schirner M; Reusch P; Barleon B; Marmé D; Martiny-Baron G
Proc Natl Acad Sci U S A; 1998 Apr; 95(8):4625-9. PubMed ID: 9539788
[TBL] [Abstract][Full Text] [Related]
10. Cysteine 116 participates in intermolecular bonding of the human VEGF(121) homodimer.
Gaspar NJ; Jue RA; Hu J; Puchacz E; deForest NL; Schellenberger U
Arch Biochem Biophys; 2002 Aug; 404(1):126-35. PubMed ID: 12127077
[TBL] [Abstract][Full Text] [Related]
11. The in vivo bioactivity of vascular endothelial growth factor/vascular permeability factor is independent of N-linked glycosylation.
Walter DH; Hink U; Asahara T; Van Belle E; Horowitz J; Tsurumi Y; Vandlen R; Heinsohn H; Keyt B; Ferrara N; Symes JF; Isner JM
Lab Invest; 1996 Feb; 74(2):546-56. PubMed ID: 8780172
[TBL] [Abstract][Full Text] [Related]
12. Crystal structure at 1.7 A resolution of VEGF in complex with domain 2 of the Flt-1 receptor.
Wiesmann C; Fuh G; Christinger HW; Eigenbrot C; Wells JA; de Vos AM
Cell; 1997 Nov; 91(5):695-704. PubMed ID: 9393862
[TBL] [Abstract][Full Text] [Related]
13. Crystallization of the receptor binding domain of vascular endothelial growth factor.
Christinger HW; Muller YA; Berleau LT; Keyt BA; Cunningham BC; Ferrara N; de Vos AM
Proteins; 1996 Nov; 26(3):353-7. PubMed ID: 8953654
[TBL] [Abstract][Full Text] [Related]
14. The crystal structure of vascular endothelial growth factor (VEGF) refined to 1.93 A resolution: multiple copy flexibility and receptor binding.
Muller YA; Christinger HW; Keyt BA; de Vos AM
Structure; 1997 Oct; 5(10):1325-38. PubMed ID: 9351807
[TBL] [Abstract][Full Text] [Related]
15. Extracellular cleavage of the vascular endothelial growth factor 189-amino acid form by urokinase is required for its mitogenic effect.
Plouët J; Moro F; Bertagnolli S; Coldeboeuf N; Mazarguil H; Clamens S; Bayard F
J Biol Chem; 1997 May; 272(20):13390-6. PubMed ID: 9148962
[TBL] [Abstract][Full Text] [Related]
16. Structural requirements for dimerization, glycosylation, secretion, and biological function of VPF/VEGF.
Claffey KP; Senger DR; Spiegelman BM
Biochim Biophys Acta; 1995 Jan; 1246(1):1-9. PubMed ID: 7811723
[TBL] [Abstract][Full Text] [Related]
17. VEGF and the Fab fragment of a humanized neutralizing antibody: crystal structure of the complex at 2.4 A resolution and mutational analysis of the interface.
Muller YA; Chen Y; Christinger HW; Li B; Cunningham BC; Lowman HB; de Vos AM
Structure; 1998 Sep; 6(9):1153-67. PubMed ID: 9753694
[TBL] [Abstract][Full Text] [Related]
18. Vascular endothelial growth factor: crystal structure and functional mapping of the kinase domain receptor binding site.
Muller YA; Li B; Christinger HW; Wells JA; Cunningham BC; de Vos AM
Proc Natl Acad Sci U S A; 1997 Jul; 94(14):7192-7. PubMed ID: 9207067
[TBL] [Abstract][Full Text] [Related]
19. Single-chain vascular endothelial growth factor variant with antagonist activity.
Boesen TP; Soni B; Schwartz TW; Halkier T
J Biol Chem; 2002 Oct; 277(43):40335-41. PubMed ID: 12151391
[TBL] [Abstract][Full Text] [Related]
20. A novel vascular endothelial growth factor encoded by Orf virus, VEGF-E, mediates angiogenesis via signalling through VEGFR-2 (KDR) but not VEGFR-1 (Flt-1) receptor tyrosine kinases.
Meyer M; Clauss M; Lepple-Wienhues A; Waltenberger J; Augustin HG; Ziche M; Lanz C; Büttner M; Rziha HJ; Dehio C
EMBO J; 1999 Jan; 18(2):363-74. PubMed ID: 9889193
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
